NEW YORK, July 3-A group of six Pennsylvania cancer institutes will launch a bioinformatics consortium for cancer research with $5.5 million from the state tobacco settlement fund, the University of Pittsburgh Cancer Institute said yesterday.
The project will build a database of clinical trial information, set up a biorepository of serum and tissue samples, and coordinate the bioinformatics data from all six member institutions.
The member institutes have formed a consortium called the Pennsylvania Cancer Alliance. It includes the UPCI, Fox Chase Cancer Center, Thomas Jefferson University's Kimmel Cancer Center, the University of Pennsylvania's Abramson Cancer Center, Penn State Cancer Institute and the Wistar Institute.
Members will also collaborate with biotech companies and other Pennsylvania researchers.
Aims include identifying new biomarkers for cancer, improving cancer type classification and allowing for more accurate disease prognosis.
The Pennsylvania Department of Health will fund the consortium through funds established by a settlement between the state and tobacco companies.